This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hedges, S. R.
Right arrow Articles by Russell, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hedges, S. R.
Right arrow Articles by Russell, M. W.

 Previous Article  |  Next Article 

Infection and Immunity, December 1998, p. 5826-5832, Vol. 66, No. 12
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Evaluation of Immunoglobulin A1 (IgA1) Protease and IgA1 Protease-Inhibitory Activity in Human Female Genital Infection with Neisseria gonorrhoeae

Spencer R. Hedges,1,* Matthew S. Mayo,2 Lisa Kallman,1 Jiri Mestecky,1,3 Edward W. Hook III,3 and Michael W. Russell1

Departments of Microbiology1 and Medicine3 and Biostatistics Unit of the Comprehensive Cancer Center,2 University of Alabama at Birmingham, Birmingham, Alabama

Received 12 May 1998/Returned for modification 25 June 1998/Accepted 1 September 1998

Immunoglobulin A1 (IgA1) protease, an enzyme that selectively cleaves human IgA1, may be a virulence factor for pathogenic organisms such as Neisseria gonorrhoeae. Host protection from the effects of IgA1 protease includes antibody-mediated inhibition of IgA1 protease activity, and it is believed that the relative balance between IgA1 protease and inhibitory antibodies contributes to the pathogenesis of disease caused by IgA1 protease-producing organisms. We have examined the levels of these two opposing factors in genital tract secretions and sera from women with uncomplicated infection with N. gonorrhoeae. When IgA1 in cervical mucus was examined by Western blotting, no evidence of cleavage fragments characteristic of IgA1 protease activity was seen in gonococcus-infected or control patients. Cleavage fragments typical of IgA1 protease were detected, however, after the addition of exogenous IgA1 protease to cervical mucus. Degraded IgA1 was detected in some vaginal wash samples, but the fragment pattern was not typical of IgA1 protease activity. All N. gonorrhoeae isolates from the infected patients produced IgA1 protease in vitro. All but two serum samples and 16 of 65 cervical mucus samples displayed inhibitory activity against gonococcal IgA1 protease, but there was no significant difference in the level of inhibitory activity between gonococcus-infected and noninfected patients in either cervical mucus or serum. There was no difference in the levels of IgA1 protease-inhibitory activity in serum or cervical mucus collected from patients at recruitment and 2 weeks later. These results suggest that cleavage of IgA1 by gonococcal IgA1 protease within the lumen of the female lower genital tract is unlikely to be a significant factor in the pathogenesis of infections by N. gonorrhoeae.

* Corresponding author. Mailing address: Department of Microbiology, BBRB Box 1, University of Alabama at Birmingham, 845 19th St. South, Birmingham, AL 35294-2170. Phone: (205) 975-2463. Fax: (205) 934-3894. E-mail: medm136{at}uabdpo.dpo.uab.edu.

Infection and Immunity, December 1998, p. 5826-5832, Vol. 66, No. 12
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Lomholt, J. A., Kilian, M. (2008). Degradation of Uniquely Glycosylated Secretory Immunoglobulin A in Tears from Patients with Pseudomonas aeruginosa Keratitis. IOVS 49: 4939-4944 [Abstract] [Full Text]  
  • Henderson, I. R., Navarro-Garcia, F., Desvaux, M., Fernandez, R. C., Ala'Aldeen, D. (2004). Type V Protein Secretion Pathway: the Autotransporter Story. Microbiol. Mol. Biol. Rev. 68: 692-744 [Abstract] [Full Text]  
  • Tsirpouchtsidis, A., Hurwitz, R., Brinkmann, V., Meyer, T. F., Haas, G. (2002). Neisserial Immunoglobulin A1 Protease Induces Specific T-Cell Responses in Humans. Infect. Immun. 70: 335-344 [Abstract] [Full Text]  
  • Wiggins, R, Hicks, S J, Soothill, P W, Millar, M R, Corfield, A P (2001). Mucinases and sialidases: their role in the pathogenesis of sexually transmitted infections in the female genital tract. Sex. Transm. Infect. 77: 402-408 [Abstract] [Full Text]  
  • Henderson, I. R., Nataro, J. P. (2001). Virulence Functions of Autotransporter Proteins. Infect. Immun. 69: 1231-1243 [Full Text]  
  • Hopper, S., Vasquez, B., Merz, A., Clary, S., Wilbur, J. S., So, M. (2000). Effects of the Immunoglobulin A1 Protease on Neisseria gonorrhoeae Trafficking across Polarized T84 Epithelial Monolayers. Infect. Immun. 68: 906-911 [Abstract] [Full Text]  
  • Kirkeby, L., Rasmussen, T. T., Reinholdt, J., Kilian, M. (2000). Immunoglobulins in Nasal Secretions of Healthy Humans: Structural Integrity of Secretory Immunoglobulin A1 (IgA1) and Occurrence of Neutralizing Antibodies to IgA1 Proteases of Nasal Bacteria. CVI 7: 31-39 [Abstract] [Full Text]  
  • Jerse, A. E. (1999). Experimental Gonococcal Genital Tract Infection and Opacity Protein Expression in Estradiol-Treated Mice. Infect. Immun. 67: 5699-5708 [Abstract] [Full Text]  
  • Johannsen, D. B., Johnston, D. M., Koymen, H. O., Cohen, M. S., Cannon, J. G. (1999). A Neisseria gonorrhoeae Immunoglobulin A1 Protease Mutant Is Infectious in the Human Challenge Model of Urethral Infection. Infect. Immun. 67: 3009-3013 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»